Sande C - Search Results

1

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.

Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE Jr, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Lemey P, Libster R, Löwensteyn Y, Mejias A, Munoz FM, Munywoki PK, Mwananyanda L, Nair H, Nunes MC, Ramilo O, Richmond P, Ruckwardt TJ, Sande C, Srikantiah P, Thacker N, Waldstein KA, Weinberger D, Wildenbeest J, Wiseman D, Zar HJ, Zambon M, Bont L. Mazur NI, et al. Among authors: sande c. Lancet Infect Dis. 2023 Jan;23(1):e2-e21. doi: 10.1016/S1473-3099(22)00291-2. Epub 2022 Aug 8. Lancet Infect Dis. 2023. PMID: 35952703 Free PMC article. Review.

2

Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumonia.

Sande CJ, Mutunga MN, Medley GF, Cane PA, Nokes DJ. Sande CJ, et al. J Infect Dis. 2013 Feb 1;207(3):489-92. doi: 10.1093/infdis/jis700. Epub 2012 Nov 21. J Infect Dis. 2013. PMID: 23175761 Free PMC article.

3

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.

Nyiro JU, Sande C, Mutunga M, Kiyuka PK, Munywoki PK, Scott JA, Nokes DJ. Nyiro JU, et al. Among authors: sande c. Vaccine. 2015 Apr 8;33(15):1797-801. doi: 10.1016/j.vaccine.2015.02.039. Epub 2015 Feb 26. Vaccine. 2015. PMID: 25725445 Free PMC article.

4

Best practice in the prevention and management of paediatric respiratory syncytial virus infection.

Drysdale SB, Green CA, Sande CJ. Drysdale SB, et al. Ther Adv Infect Dis. 2016 Apr;3(2):63-71. doi: 10.1177/2049936116630243. Epub 2016 Feb 10. Ther Adv Infect Dis. 2016. PMID: 27034777 Free PMC article. Review.

5

Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.

Nyiro JU, Sande CJ, Mutunga M, Kiyuka PK, Munywoki PK, Scott JA, Nokes DJ. Nyiro JU, et al. PLoS One. 2016 Nov 16;11(11):e0166706. doi: 10.1371/journal.pone.0166706. eCollection 2016. PLoS One. 2016. PMID: 27851799 Free PMC article.

6

Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.

Nyiro JU, Kombe IK, Sande CJ, Kipkoech J, Kiyuka PK, Onyango CO, Munywoki PK, Kinyanjui TM, Nokes DJ. Nyiro JU, et al. PLoS One. 2017 May 22;12(5):e0177803. doi: 10.1371/journal.pone.0177803. eCollection 2017. PLoS One. 2017. PMID: 28531224 Free PMC article.

7

Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal Kenya.

Nyiro JU, Kiyuka PK, Mutunga MN, Sande CJ, Munywoki PK, Scott JAG, Nokes DJ. Nyiro JU, et al. Wellcome Open Res. 2019 Feb 18;4:33. doi: 10.12688/wellcomeopenres.15108.1. eCollection 2019. Wellcome Open Res. 2019. PMID: 30906883 Free PMC article.

8

Vaccination against Respiratory Syncytial Virus.

Green CA, Drysdale SB, Pollard AJ, Sande CJ. Green CA, et al. Interdiscip Top Gerontol Geriatr. 2020;43:182-192. doi: 10.1159/000504477. Epub 2020 Apr 9. Interdiscip Top Gerontol Geriatr. 2020. PMID: 32305982 Review.

9

Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).

Jefferies K, Drysdale SB, Robinson H, Clutterbuck EA, Blackwell L, McGinley J, Lin GL, Galal U, Nair H, Aerssens J, Öner D, Langedijk A, Bont L, Wildenbeest JG, Martinon-Torres F, Rodríguez-Tenreiro Sánchez C, Nadel S, Openshaw P, Thwaites R, Widjojoatmodjo M, Zhang L, Nguyen TL, Giaquinto C, Giordano G, Baraldi E, Pollard AJ; RESCEU Investigators. Jefferies K, et al. J Infect Dis. 2020 Oct 7;222(Suppl 7):S658-S665. doi: 10.1093/infdis/jiaa239. J Infect Dis. 2020. PMID: 32794560

10

Implementation strategies for passive respiratory syncytial virus immunisation.

Sande CJ. Sande CJ. Lancet Infect Dis. 2021 Sep;21(9):1200-1201. doi: 10.1016/S1473-3099(20)30717-9. Epub 2021 May 6. Lancet Infect Dis. 2021. PMID: 33965061 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page